KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueEBIATGross ProfitLeasesLong-Term Debt IssuancesOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetReceivables - OtherShares OutstandingShares OutstandingShort-Term Debt issuancesShort-Term Debt repayments
Ratios

Elanco Animal Health (ELAN) Shares Outstanding (2017 - 2026)

Elanco Animal Health's Shares Outstanding history spans 9 years, with the latest figure at $497.0 million for Q4 2025.

  • On a quarterly basis, Shares Outstanding rose 0.51% to $497.0 million in Q4 2025 year-over-year; TTM through Dec 2025 was $497.0 million, a 0.51% increase, with the full-year FY2025 number at $497.0 million, up 0.51% from a year prior.
  • Shares Outstanding hit $497.0 million in Q4 2025 for Elanco Animal Health, roughly flat from $496.8 million in the prior quarter.
  • Over the last five years, Shares Outstanding for ELAN hit a ceiling of $497.0 million in Q4 2025 and a floor of $473.0 million in Q1 2021.
  • Historically, Shares Outstanding has averaged $486.1 million across 5 years, with a median of $492.6 million in 2023.
  • Biggest five-year swings in Shares Outstanding: increased 18.61% in 2021 and later rose 0.23% in 2022.
  • Tracing ELAN's Shares Outstanding over 5 years: stood at $473.1 million in 2021, then rose by 0.23% to $474.2 million in 2022, then rose by 3.92% to $492.8 million in 2023, then rose by 0.33% to $494.4 million in 2024, then rose by 0.51% to $497.0 million in 2025.
  • Business Quant data shows Shares Outstanding for ELAN at $497.0 million in Q4 2025, $496.8 million in Q3 2025, and $496.6 million in Q2 2025.